These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 8348392

  • 1. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL, Ambrosioni E, De Divitiis O, Di Somma S, Rosiello G, Trimarco B.
    Clin Ther; 1991 Jun; 13(4):500-10. PubMed ID: 1934003
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 4. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Jun; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 5. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group.
    Curr Med Res Opin; 2001 Jun; 17(1):43-50. PubMed ID: 11464446
    [Abstract] [Full Text] [Related]

  • 6. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ, Scott RS, Sharpe DN, Nye ER, Charleson H, French JK, White HD, Reuben S, Maling TJ, Lewis GR.
    Med J Aust; 1991 Oct 07; 155(7):433-6. PubMed ID: 1921811
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M, Bonnefous F, Debbas N, Irvine A.
    Arch Intern Med; 1994 Feb 28; 154(4):441-9. PubMed ID: 8117177
    [Abstract] [Full Text] [Related]

  • 8. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 28; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 9. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N, Ramires JA.
    Arq Bras Cardiol; 1991 Sep 28; 57(3):253-61. PubMed ID: 1824203
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P, Walters EJ, Cullen EI, Niecestro R, Friedhoff LT.
    Curr Med Res Opin; 2004 Jan 28; 20(1):13-8. PubMed ID: 14741066
    [Abstract] [Full Text] [Related]

  • 11. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Jan 28; 11(2):247-57. PubMed ID: 2736571
    [Abstract] [Full Text] [Related]

  • 12. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991 Jan 28; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 13. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 28; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L, Mata P, Gagné C, Sirah W, Cho M, Johnson-Levonas AO, Meehan A, Troxell JK, Gumbiner B, Ezetimibe Study Group.
    Clin Ther; 2005 Feb 28; 27(2):174-84. PubMed ID: 15811480
    [Abstract] [Full Text] [Related]

  • 15. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 28; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999 Jun 28; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

  • 17. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC, Baranova E, Okopien B, Weisskopf M, Kandra A, Ferber P.
    Clin Ther; 2008 Oct 28; 30(10):1782-93. PubMed ID: 19014834
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P, Colombo F, Cattaneo R, Geroli L, Venco A.
    Int J Clin Pharmacol Res; 1992 Oct 28; 12(2):65-70. PubMed ID: 1428300
    [Abstract] [Full Text] [Related]

  • 19. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S, Bentivoglio M, Conti R, Osanna RA, Savino K, Zollino L, Corea L.
    Cardiologia; 1990 Apr 28; 35(4):335-40. PubMed ID: 2245435
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D, Morgan C, Rigby RJ, Westhuyzen J.
    Am J Kidney Dis; 2002 Feb 28; 39(2):283-90. PubMed ID: 11840368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.